Philip I. Datlow

Array ( [id] => 3416422 [patent_doc_number] => 05393753 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-02-28 [patent_title] => 'Substituted imidazobenzazepines' [patent_app_type] => 1 [patent_app_number] => 8/039038 [patent_app_country] => US [patent_app_date] => 1993-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6887 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 433 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/393/05393753.pdf [firstpage_image] =>[orig_patent_app_number] => 039038 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2894729 [patent_doc_number] => 05270464 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-12-14 [patent_title] => 'Anti-HIV-1 tetrahydroimidazo[1,4]benzodiazepin-2-(thi) ones' [patent_app_type] => 1 [patent_app_number] => 8/042858 [patent_app_country] => US [patent_app_date] => 1993-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26112 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/270/05270464.pdf [firstpage_image] =>[orig_patent_app_number] => 042858 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3458399 [patent_doc_number] => 05472968 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-12-05 [patent_title] => 'Spiro[cycloalkylbenzene-1,1\'-(1\',2\',3\',4\'-tetrahydro-isoquinolines)] having neuroprotective properties' [patent_app_type] => 1 [patent_app_number] => 7/975932 [patent_app_country] => US [patent_app_date] => 1993-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4944 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/472/05472968.pdf [firstpage_image] =>[orig_patent_app_number] => 975932 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3007273 [patent_doc_number] => 05374722 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-12-20 [patent_title] => 'Bridged benzazepines' [patent_app_type] => 1 [patent_app_number] => 8/027167 [patent_app_country] => US [patent_app_date] => 1993-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8966 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/374/05374722.pdf [firstpage_image] =>[orig_patent_app_number] => 027167 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3428184 [patent_doc_number] => 05462934 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-10-31 [patent_title] => 'Condensed heterocyclic ketone derivatives and their use' [patent_app_type] => 1 [patent_app_number] => 8/026041 [patent_app_country] => US [patent_app_date] => 1993-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26410 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 144 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/462/05462934.pdf [firstpage_image] =>[orig_patent_app_number] => 026041 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3122879 [patent_doc_number] => 05384316 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-01-24 [patent_title] => '4,16-diazatetracyclo[23.3.1.1.Hu 14,17=b . 0 Hu 4,9 triaconta-16,19-diene-2,3,10-trione derivatives' [patent_app_type] => 1 [patent_app_number] => 7/975544 [patent_app_country] => US [patent_app_date] => 1993-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3988 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/384/05384316.pdf [firstpage_image] =>[orig_patent_app_number] => 975544 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3027836 [patent_doc_number] => 05348949 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-09-20 [patent_title] => 'Method of preparing N-oxo-tetrahydro-.beta.-carbolines' [patent_app_type] => 1 [patent_app_number] => 8/016675 [patent_app_country] => US [patent_app_date] => 1993-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4557 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 202 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/348/05348949.pdf [firstpage_image] =>[orig_patent_app_number] => 016675 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3066034 [patent_doc_number] => 05294618 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-03-15 [patent_title] => 'Octahydrobenzisoquinoline derivatives as antipsychotic agents' [patent_app_type] => 1 [patent_app_number] => 8/017367 [patent_app_country] => US [patent_app_date] => 1993-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11581 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 172 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/294/05294618.pdf [firstpage_image] =>[orig_patent_app_number] => 017367 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3031931 [patent_doc_number] => 05342938 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-08-30 [patent_title] => 'Benzoxazine intermediates' [patent_app_type] => 1 [patent_app_number] => 8/014022 [patent_app_country] => US [patent_app_date] => 1993-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4999 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/342/05342938.pdf [firstpage_image] =>[orig_patent_app_number] => 014022 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3085580 [patent_doc_number] => 05284841 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-02-08 [patent_title] => 'Benzo-fused lactams promote release of growth hormone' [patent_app_type] => 1 [patent_app_number] => 8/013448 [patent_app_country] => US [patent_app_date] => 1993-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28414 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1311 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/284/05284841.pdf [firstpage_image] =>[orig_patent_app_number] => 013448 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3052946 [patent_doc_number] => 05344831 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-09-06 [patent_title] => 'Diazabicyclo derivatives' [patent_app_type] => 1 [patent_app_number] => 8/010145 [patent_app_country] => US [patent_app_date] => 1993-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10921 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/344/05344831.pdf [firstpage_image] =>[orig_patent_app_number] => 010145 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3037746 [patent_doc_number] => 05373008 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-12-13 [patent_title] => 'Phenylamidine and phenylguanidine derivatives and their use as anti-diabetic agents' [patent_app_type] => 1 [patent_app_number] => 8/009807 [patent_app_country] => US [patent_app_date] => 1993-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28469 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 361 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/373/05373008.pdf [firstpage_image] =>[orig_patent_app_number] => 009807 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2968718 [patent_doc_number] => 05258384 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-11-02 [patent_title] => 'S-11-hydroxy-10-methylaporphine and its biologically active salt forms as 5HT.sub.1A inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/007812 [patent_app_country] => US [patent_app_date] => 1993-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3951 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/258/05258384.pdf [firstpage_image] =>[orig_patent_app_number] => 007812 [rel_patent_id] =>[rel_patent_doc_number] =>)